These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32518378)

  • 1. Age-independent increasing prevalence of Human Papillomavirus-driven oropharyngeal carcinomas in North-East Italy.
    Del Mistro A; Frayle H; Menegaldo A; Favaretto N; Gori S; Nicolai P; Spinato G; Romeo S; Tirelli G; da Mosto MC; Polesel J; Boscolo Rizzo P
    Sci Rep; 2020 Jun; 10(1):9320. PubMed ID: 32518378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low prevalence of HPV-driven head and neck squamous cell carcinoma in North-East Italy.
    Baboci L; Holzinger D; Boscolo-Rizzo P; Tirelli G; Spinato R; Lupato V; Fuson R; Schmitt M; Michel A; Halec G; Da Mosto MC; Pawlita M; Del Mistro A
    Papillomavirus Res; 2016 Dec; 2():133-140. PubMed ID: 29074172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
    Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
    Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
    Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
    Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival.
    Fossum GH; Lie AK; Jebsen P; Sandlie LE; Mork J
    Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):4003-4010. PubMed ID: 28933005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV-driven oropharyngeal cancer burden in Paris and its region (ILE DE FRANCE) from 1981 TO 2021.
    Mirghani H; Tendron A; Auperin A; Casiraghi O; Classe M; Badoual C; Legoupil C; Puech J; Veyer D; Dalstein V; Pere H; Gorphe P
    Cancer Epidemiol; 2024 Aug; 91():102603. PubMed ID: 38901087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southeast Scotland.
    Wells LA; Junor EJ; Conn B; Pattle S; Cuschieri K
    J Clin Pathol; 2015 Oct; 68(10):849-52. PubMed ID: 26152733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of human papillomavirus DNA and p16
    Olesen TB; Sand FL; Rasmussen CL; Albieri V; Toft BG; Norrild B; Munk C; Kjær SK
    Lancet Oncol; 2019 Jan; 20(1):145-158. PubMed ID: 30573285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.
    Holzinger D; Schmitt M; Dyckhoff G; Benner A; Pawlita M; Bosch FX
    Cancer Res; 2012 Oct; 72(19):4993-5003. PubMed ID: 22991302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
    Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
    Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
    Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonuniform Distribution of High-risk Human Papillomavirus in Squamous Cell Carcinomas of the Oropharynx: Rethinking the Anatomic Boundaries of Oral and Oropharyngeal Carcinoma From an Oncologic HPV Perspective.
    Gelwan E; Malm IJ; Khararjian A; Fakhry C; Bishop JA; Westra WH
    Am J Surg Pathol; 2017 Dec; 41(12):1722-1728. PubMed ID: 28877058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocal human papillomavirus detection in palatine and pharyngeal tonsils.
    Murono S; Yoshida H; Kobayashi T; Kawase T; Kikuchi D; Suzuki T; Nakanishi Y; Endo K; Kondo S; Wakisaka N; Yoshizaki T
    Acta Otolaryngol; 2018 May; 138(5):483-486. PubMed ID: 29187118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
    JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus infection and p16 overexpression in oropharyngeal squamous cell carcinoma: a case series from 2010 to 2014.
    Donà MG; Spriano G; Pichi B; Rollo F; Laquintana V; Covello R; Pellini R; Giuliani M; Pescarmona E; Benevolo M
    Future Microbiol; 2015; 10(8):1283-91. PubMed ID: 26228531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging risk of oropharyngeal and oral cavity cancer in HPV-related subsites in young people in Brazil.
    Menezes FDS; Latorre MDRDO; Conceição GMS; Curado MP; Antunes JLF; Toporcov TN
    PLoS One; 2020; 15(5):e0232871. PubMed ID: 32407339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe.
    Mena M; Frias-Gomez J; Taberna M; Quirós B; Marquez S; Clavero O; Baena A; Lloveras B; Alejo M; León X; García J; Mesía R; Bermejo O; Bonfill T; Aguila A; Guix M; Hijano R; Pavón MA; Torres M; Tous S; Clèries R; Alemany L
    Sci Rep; 2020 Aug; 10(1):13219. PubMed ID: 32764593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.